Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer

Clinical trial NCT02649101 · UNKNOWN

Trial details

NCT number: NCT02649101
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2015-10-01
Primary completion: 2017-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.